| Not Yet Recruiting | Pacritinib With Aza for Upfront Myelodysplastic Syndrome NCT07387354 | Thomas Jefferson University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Clonal Hematopoiesis of Immunological Significance NCT05969821 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia NCT07257640 | Zhejiang University | Phase 1 |
| Recruiting | HEME Home Transfusion Program NCT06487247 | Dana-Farber Cancer Institute | N/A |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants NCT06797375 | Rallybio | Phase 1 |
| Recruiting | The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease NCT06795815 | Azienda USL Reggio Emilia - IRCCS | N/A |
| Withdrawn | A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients NCT03097796 | Pulmotect, Inc. | Phase 1 |
| Recruiting | Study on the Clinical Efficacy of Teclistamab NCT06477783 | Universitaire Ziekenhuizen KU Leuven | — |
| Recruiting | Autologous Testicular Tissue Transplantation NCT05414045 | Universitair Ziekenhuis Brussel | N/A |
| Recruiting | The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common H NCT06857604 | Meyer Children's Hospital IRCCS | N/A |
| Active Not Recruiting | Autologous Transplantation of Human Cryopreserved Testis Tissue NCT07364409 | Herlev and Gentofte Hospital | N/A |
| Enrolling By Invitation | Visual and Auditory Distraction for the Relief of Pain and Anxiety NCT07023692 | Region Skane | N/A |
| Completed | Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases NCT06350526 | New Valley University | — |
| Recruiting | Clinical Study of Combined Platelet Transfusion NCT06613425 | The General Hospital of Western Theater Command | Phase 4 |
| Recruiting | A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study NCT06271252 | OriCell Therapeutics Co., Ltd. | Phase 1 |
| Withdrawn | The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune NCT06291415 | Hutchmed | Phase 1 |
| Recruiting | The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research NCT06222164 | Invivoscribe, Inc. | — |
| Recruiting | Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger NCT06187831 | Thomas Kander | — |
| Active Not Recruiting | Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant NCT04167683 | Rigshospitalet, Denmark | — |
| Active Not Recruiting | Muscle Dysfunction in Patients With Haematological Diseases NCT05150561 | Rigshospitalet, Denmark | — |
| Terminated | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placeb NCT05660265 | GlaxoSmithKline | Phase 1 |
| Recruiting | Hypnosis and Virtual Reality in Bone Marrow Examination NCT05982249 | Bnai Zion Medical Center | N/A |
| Recruiting | Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathol NCT06304194 | Meyer Children's Hospital IRCCS | N/A |
| Recruiting | Naturopathic-pharmacological Consultation in Hematology NCT05982262 | Bnai Zion Medical Center | N/A |
| Completed | Evaluation of ClearLLab LS Screening Panel NCT05819762 | Beckman Coulter, Inc. | — |
| Unknown | Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors NCT05755854 | Anhui Provincial Hospital | Phase 1 |
| Completed | RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL NCT05902845 | Xiaoyu Zhu | EARLY_Phase 1 |
| Recruiting | CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases NCT05827835 | Zhejiang University | Phase 1 / Phase 2 |
| Completed | Multiple Myeloma Prognostic Indices NCT06095752 | Assiut University | — |
| Unknown | Hematological Abnormalities in Children NCT05541835 | Assiut University | — |
| Completed | Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiat NCT05895994 | MEI HENG | EARLY_Phase 1 |
| Completed | Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster O NCT05907603 | Kai Lin Xu，MD | EARLY_Phase 1 |
| Terminated | A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) NCT05641324 | Anaveon AG | Phase 1 |
| Completed | CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL NCT05716113 | He Huang | EARLY_Phase 1 |
| Terminated | Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management NCT05351866 | Limbix Health, Inc. | N/A |
| Enrolling By Invitation | Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes NCT05443321 | Brigham and Women's Hospital | N/A |
| Unknown | Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support NCT06148610 | Fonds de Dotation HTC Project | — |
| Withdrawn | CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies NCT04282174 | Baptist Health South Florida | Phase 2 |
| Completed | Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis NCT05487794 | University of Sao Paulo | N/A |
| Recruiting | Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation NCT06809699 | He Huang | Phase 1 |
| Recruiting | Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thal NCT05477563 | Vertex Pharmaceuticals Incorporated | Phase 3 |
| Active Not Recruiting | Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia NCT05356195 | Vertex Pharmaceuticals Incorporated | Phase 3 |
| Unknown | A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received O NCT05298683 | Hellenic Society of Hematology | Phase 2 |
| Unknown | A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by I NCT05147493 | Hellenic Society of Hematology | Phase 2 |
| Recruiting | Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx NCT05196789 | Peter MacCallum Cancer Centre, Australia | — |
| Withdrawn | Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation NCT05587881 | The First Affiliated Hospital of Soochow University | — |
| Unknown | Monitoring Risks for Hematological Changes in Gas Station Workers NCT05135078 | Sohag University | — |
| Not Yet Recruiting | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Re NCT05126186 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Unknown | mNGS Versus Blood Culture in FN NCT05149547 | Peking University People's Hospital | — |
| Withdrawn | Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy Procedures NCT05102331 | Case Comprehensive Cancer Center | N/A |
| Completed | A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants NCT05015920 | Shanghai BDgene Co., Ltd. | N/A |
| Completed | Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Cen NCT05074706 | University of Milano Bicocca | — |
| Completed | National Project on Vaccines, COVID-19 and Frail Patients NCT04848493 | Azienda USL Reggio Emilia - IRCCS | — |
| Recruiting | Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Ad NCT04640987 | Porteus, Matthew, MD | Phase 1 |
| Recruiting | Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospital NCT05378139 | University Hospital Bispebjerg and Frederiksberg | — |
| Enrolling By Invitation | A Long-term Follow-up Study in Participants Who Received CTX001 NCT04208529 | Vertex Pharmaceuticals Incorporated | Phase 3 |
| Completed | Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT NCT04412811 | Gruppo Italiano Trapianto di Midollo Osseo | — |
| Completed | Effects of Music Therapy on Sleep Quality in Patients Who Had Hematopoietic Stem Cell Transplantation NCT05015140 | Istanbul University - Cerrahpasa | N/A |
| Completed | Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease NCT04584528 | Duke University | N/A |
| Completed | Safety and Tolerability Evaluation of MaaT033 NCT04150393 | MaaT Pharma | Phase 1 |
| Unknown | Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) NCT04720144 | Centre Hospitalier Universitaire Vaudois | — |
| Completed | Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation NCT04094844 | University of Michigan Rogel Cancer Center | N/A |
| Completed | Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") NCT04474678 | Medical University of Vienna | N/A |
| Unknown | Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood Cells NCT04551235 | National Taiwan University Hospital | — |
| Unknown | PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant NCT04243434 | Acrotech Biopharma Inc. | Phase 1 |
| Enrolling By Invitation | Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors NCT04450927 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Unknown | Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma NCT04309084 | Celularity Incorporated | Phase 1 |
| Terminated | Natural Killer Cell (CYNK-001) Infusions in Adults with AML NCT04310592 | Celularity Incorporated | Phase 1 |
| Active Not Recruiting | Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogenei NCT03842696 | University of Michigan Rogel Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults NCT04249830 | Alice Bertaina | N/A |
| Not Yet Recruiting | Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Dependin NCT04209829 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease NCT04039100 | Rigshospitalet, Denmark | N/A |
| Completed | Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy NCT04168983 | University Hospital, Caen | N/A |
| Completed | Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disea NCT03918343 | Centre Hospitalier Universitaire de Besancon | N/A |
| Completed | Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant NCT03886909 | Milton S. Hershey Medical Center | N/A |
| Recruiting | Rapid Analysis of Infections by Spectrometry of Exhaled Breath NCT03299608 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Oligosaccharide for Cdiff(+) Heme-onc Patients NCT03778606 | Medical College of Wisconsin | N/A |
| Completed | ALLO-SCT in Elderly Patients With Hematological Disease NCT04386928 | Gruppo Italiano Trapianto di Midollo Osseo | — |
| Completed | Multimodal Sexual Dysfunction Intervention In HCT NCT03803696 | Massachusetts General Hospital | N/A |
| Completed | Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals NCT03734588 | Spark Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy NCT03876301 | Spark Therapeutics, Inc. | — |
| Completed | Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukem NCT03578367 | Novartis Pharmaceuticals | Phase 2 |
| Completed | DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors NCT04888286 | Gruppo Italiano Trapianto di Midollo Osseo | — |
| Completed | A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia NCT03655678 | Vertex Pharmaceuticals Incorporated | Phase 2 / Phase 3 |
| Completed | Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases NCT03611257 | Seoul National University Hospital | N/A |
| Completed | Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients NCT03030248 | Medical College of Wisconsin | Phase 2 |
| Completed | Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer NCT03488641 | German Cancer Research Center | — |
| Completed | Thrombosomes® in Bleeding Thrombocytopenic Patients NCT03394755 | Cellphire Therapeutics, Inc. | Phase 1 |
| Completed | Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial NCT03342495 | University of Calgary | N/A |
| Completed | Clinical Use of Pathogen Reduced Red Blood Cell Suspension NCT03426553 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 3 |
| Completed | Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer NCT03356171 | Centre Hospitalier Universitaire de la Réunion | N/A |
| Completed | Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic NCT03343834 | Assistance Publique - Hôpitaux de Paris | N/A |
| Unknown | WB-EMS and Nutrition in Patients With Hematological Malignancies NCT03556748 | University of Erlangen-Nürnberg Medical School | N/A |
| Completed | A Safety and Efficacy Study of NAC in Patients With TA-TMA NCT03252925 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Completed | High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT NCT02827149 | Gruppo Italiano Trapianto di Midollo Osseo | — |
| Completed | Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS NCT03066648 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disor NCT03250845 | Universitaire Ziekenhuizen KU Leuven | — |
| Withdrawn | Observational Study of Home Administration of Carfilzomib NCT04621955 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients NCT02918695 | Universitaire Ziekenhuizen KU Leuven | — |
| Withdrawn | Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Stude NCT03041571 | University of Florida | — |
| Completed | Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Ac NCT03540654 | University Hospital, Bordeaux | — |
| Completed | SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sic NCT03006718 | Julia Finkel | N/A |
| Completed | Prospective Study of Patients With Thrombocytopenia Following HSCT NCT02487563 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Completed | Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatr NCT02329808 | Radboud University Medical Center | — |
| Unknown | Registry of Philadelphia-Negative Myeloproliferative Neoplasms NCT02380378 | Hospital Israelita Albert Einstein | — |
| Completed | The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitaliz NCT02343965 | Nantes University Hospital | N/A |
| Withdrawn | Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or T NCT02155634 | Celgene | Phase 3 |
| Unknown | Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome NCT02130882 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Completed | A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF NCT01787552 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells NCT02090803 | Institut de Cancérologie de la Loire | — |
| Unknown | A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes NCT01541631 | Catholic University of Health and Allied Sciences | N/A |
| Completed | Comparison of Educational Methods for Teaching Peripheral Blood Smears NCT02435316 | The Reading Hospital and Medical Center | N/A |
| Unknown | Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic An NCT01579110 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Completed | Steroid Treatment for Hypereosinophilic Syndrome NCT01524536 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Unknown | Effect of the Use of Simulation (Video) on the Oral Hygiene NCT01718002 | University of Sao Paulo | N/A |
| Completed | French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients NCT03313583 | Etablissement Français du Sang | — |
| Completed | Ultra Low Dose Interleukin-2 in Healthy Volunteers NCT01445561 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Completed | Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phas NCT01511289 | Il-Yang Pharm. Co., Ltd. | Phase 3 |
| Active Not Recruiting | Gulf Long-Term Follow-Up Study NCT01287000 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Completed | Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patien NCT01114165 | University Hospital Muenster | Phase 4 |
| Completed | Ondansetron Versus Aprepitant Plus Ondansetron for Emesis NCT00954941 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Integrated Whole-Genome Analysis of Hematologic Disorders NCT01108159 | Stanford University | — |
| Completed | Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing NCT00909207 | M.D. Anderson Cancer Center | — |
| Completed | Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide NCT00800839 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI NCT01602952 | Il-Yang Pharm. Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation NCT00856505 | University Hospital Freiburg | Phase 1 / Phase 2 |
| Completed | ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding NCT00616460 | HaEmek Medical Center, Israel | Phase 3 |
| Completed | Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Pat NCT00561639 | University Hospital, Grenoble | — |
| Withdrawn | A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropen NCT00520325 | Enzon Pharmaceuticals, Inc. | Phase 1 |
| Terminated | Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) NCT00579111 | Baylor College of Medicine | Phase 1 / Phase 2 |
| Completed | Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients NCT02108444 | Peking University | — |
| Terminated | Stroke With Transfusions Changing to Hydroxyurea NCT00122980 | St. Jude Children's Research Hospital | Phase 3 |
| Terminated | Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT NCT01220297 | Stanford University | Phase 2 |
| Completed | Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT NCT00350181 | Stanford University | Phase 2 |
| Unknown | Intra Bone Marrow Injection Of Unrelated Cord Blood Cells NCT00696046 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Phase 1 / Phase 2 |
| Completed | A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children NCT00213239 | The Hospital for Sick Children | Phase 1 / Phase 2 |
| Completed | SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. NCT00113893 | Scios, Inc. | Phase 2 |
| Completed | Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy V NCT00223483 | The University of Texas Health Science Center at San Antonio | — |
| Completed | Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patien NCT00993486 | Kiadis Pharma | Phase 1 / Phase 2 |
| Terminated | Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease NCT00115336 | Children's Hospital Medical Center, Cincinnati | Phase 4 |
| Completed | Molecular Epidemiology of Benzene-exposed Workers. NCT00364520 | University of Colorado, Denver | — |
| Completed | Progression of Hematopoietic Diseases in Shanghai, China NCT00365014 | University of Colorado, Denver | — |
| Completed | Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease NCT00071032 | Rutgers, The State University of New Jersey | Phase 3 |
| Completed | Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) NCT00231309 | Emory University | N/A |
| Completed | Natural History Study for BEN NCT00059423 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | HLA Matching - Unrelated Umbilical Cord Blood Transplantation NCT00179946 | Ann & Robert H Lurie Children's Hospital of Chicago | — |
| Unknown | The ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clini NCT03868527 | Hospices Civils de Lyon | — |
| Terminated | A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-C NCT00208949 | Emory University | Phase 2 |
| Terminated | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders NCT00176826 | Masonic Cancer Center, University of Minnesota | Phase 2 / Phase 3 |
| Completed | Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia NCT00006400 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) NCT00000623 | Carelon Research | — |
| Completed | Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia NCT00029380 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syn NCT00001839 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Allogeneic Cell Therapy for Adults With Hematologic Malignancies NCT00208962 | Emory University | Phase 2 |
| Completed | Cord Blood Stem Cell Transplantation Study (COBLT) NCT00000603 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Stroke Prevention in Sickle Cell Anemia (STOP 1) NCT00000592 | Augusta University | Phase 3 |
| Completed | Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG) NCT00000602 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Evaluation, Treatment, and Training for Patients With Blood Disorders NCT00001397 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemother NCT00001338 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) NCT00000586 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Trial to Reduce Alloimmunization to Platelets (TRAP) NCT00000589 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone NCT00000588 | Case Western Reserve University | Phase 2 |
| Completed | Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection NCT00000587 | Thomas Jefferson University | Phase 2 |
| Enrolling By Invitation | Bone Marrow Grafting for Leukemia and Lymphoma NCT00186147 | Stanford University | — |
| Completed | Penicillin Prophylaxis in Sickle Cell Disease (PROPS) NCT00000585 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders NCT00000597 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Cooperative Study of Factor VIII Inhibitors NCT00000582 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis NCT00000595 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |